Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
10.19
-0.19 (-1.83%)
At close: Aug 26, 2026, 4:00 PM EDT
10.55
+0.36 (3.53%)
After-hours: Aug 26, 2026, 5:05 PM EDT
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $308.3 million as of August 26, 2026. Its market cap has increased by 5.39% in one year.
Market Cap
308.30M
Enterprise Value
224.55M
1-Year Change
5.39%
Ranking
Category
Stock Price
$10.19
ChartMarket Cap Chart
Since November 14, 2023, Cartesian Therapeutics's market cap has increased from $166.07M to $308.30M, an increase of 85.65%. That is a compound annual growth rate of 24.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 308.30M | 64.44% |
| Dec 31, 2025 | 187.49M | -59.31% |
| Dec 31, 2024 | 460.74M | 330.61% |
| Dec 29, 2023 | 107.00M | -35.57% |
| Nov 14, 2023 | 166.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vicore Pharma Holding AB | 327.03M |
| YD Bio | 326.99M |
| Orchestra BioMed Holdings | 322.76M |
| Vanda Pharmaceuticals | 320.45M |
| Bicycle Therapeutics | 305.52M |
| InflaRx | 305.05M |
| Neumora Therapeutics | 302.51M |
| Anavex Life Sciences | 296.55M |